Skip to main content
. 2020 Oct 27;12(11):3148. doi: 10.3390/cancers12113148

Figure 8.

Figure 8

Model outlining the mechanism through which LDOC1 functions as an immune-modulator to attenuate the IL-1β production increased upon microbial infection of human oral cells.